Key result
High-risk carotid atherosclerotic plaques in HCMV+ patients were associated with a higher percentage of NKG2C+ NK cells compared to non-high-risk plaques (29.5% vs 16.3%; OR 1.053; P=0.026).
Why the study?
Is the expansion of NKG2C+ NK cells associated with high-risk carotid atherosclerotic plaques in HCMV seropositive patients?
Observational (n=66)
Is the expansion of NKG2C+ NK cells associated with high-risk carotid atherosclerotic plaques in HCMV seropositive patients?
Effect estimate: OR 1.053 (95% CI 1.002-1.106)
Absolute Event Rate: 29.5% vs 16.3%
p-value: p=0.026
Expansion of NKG2C+ NK cells is associated with an increased risk of carotid plaque destabilization and subclinical systemic inflammation in patients with chronic HCMV infection.
May flag higher plaque risk in HCMV+ patients; leaves open causal role and need for longitudinal validation.
OBJECTIVE: Human cytomegalovirus (HCMV), a pathogen involved in the development and progression of atherosclerosis, promotes in some individuals a marked reconfiguration of the natural killer (NK)-cell compartment whose hallmark is a persistent expansion of a peripheral blood NK-cell subset expressing the CD94/NKG2C NK receptor. We aimed to evaluate whether the HCMV-associated NK-cell compartment reconfiguration is related to carotid atherosclerotic plaque (CAP) instability. APPROACH AND RESULTS: NK receptor expression (ie, LILRB1, NKG2A, NKG2C, and killer immunoglobulin-like receptors [KIR]) by peripheral NK and T cells was evaluated in 40 patients with HCMV+ with CAP, including nonatherosclerotic strokes (n=15) and healthy subjects (n=11) as controls. High-risk CAP (n=16), defined as carotid stenosis >50% with ipsilateral neurological symptomatology in the previous 180 days, compared with non-high-risk CAP had higher %NKG2C+ NK cells (29.5 ± 22.4% versus 16.3 ± 13.2%; P=0.026; odds ratio, 1.053; 95% confidence interval, 1.002-1.106; P=0.042), with a corresponding reduction in the NKG2A+ NK subset (31.7 ± 17.8% versus 41.8 ± 15.8%; P=0.072). The proportions of NKG2C+ NK cells in high-risk CAP were inversely correlated with the CD4+/CD8+ ratio (R(Spearman)=-0.629; P=0.009) and directly with high-sensitivity C-reactive protein levels (R(Pearson) = 0.591; P=0.012), consistent with higher subclinical systemic inflammation. The intraplaque inflammatory infiltrate, evaluated in 27 CAP obtained after endarterectomy, showed a higher presence of subintimal CD3+ lymphocytes in those patients with HCMV-induced changes in the peripheral NK- and T-cell compartments. CONCLUSIONS: The expansion of NKG2C+ NK cells in patients with CAP seems to be associated with an increased risk of plaque destabilization in some patients with chronic HCMV infection.
No takes yet. Share an insight, caveat, or question.
Rodríguez et al. (2013) conducted an observational in Carotid atherosclerotic plaque in HCMV+ patients (n=66). High-risk carotid atherosclerotic plaque vs. Non-high-risk carotid atherosclerotic plaque was evaluated on Percentage of NKG2C+ NK cells (OR 1.053, 95% CI 1.002-1.106, p=0.026). High-risk carotid atherosclerotic plaques in HCMV+ patients were associated with a higher percentage of NKG2C+ NK cells compared to non-high-risk plaques (29.5% vs 16.3%; OR 1.053; P=0.026).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: